LivaNova PLC Proceeds from Sale of Productive Assets
LivaNova PLC (LIVN) reported Proceeds from Sale of Productive Assets of $7.28 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2026-02-25
- LivaNova PLC proceeds from sale of productive assets for the quarter ending 2022-03-31 was $11.00K, a 93.21% decline year-over-year.
- LivaNova PLC proceeds from sale of productive assets for the quarter ending 2021-03-31 was $162.00K, a 80.58% decline year-over-year.
- LivaNova PLC proceeds from sale of productive assets for the quarter ending 2020-03-31 was $834.00K, a 734.00% increase year-over-year.
- LivaNova PLC proceeds from sale of productive assets for the quarter ending 2019-12-31 was $756.00K, a 117.24% increase year-over-year.
- LivaNova PLC proceeds from sale of productive assets for fiscal 2025 was $7.28M, a 8080.90% increase from fiscal 2024.
- LivaNova PLC proceeds from sale of productive assets for fiscal 2024 was $89.00K, a 92.29% decline from fiscal 2023.
- LivaNova PLC proceeds from sale of productive assets for fiscal 2023 was $1.15M.
- LivaNova PLC proceeds from sale of productive assets for fiscal 2020 was $1.43M, a 13.64% increase from fiscal 2019.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 6 month as first filed | Proceeds from Sale of Productive Assets 8 month | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month | Proceeds from Sale of Productive Assets 20 month |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $7.28M 10-K · filed 2026-02-25 | ||||||
| 2024-12-31 | $89.00K 10-K · filed 2026-02-25 | ||||||
| 2023-12-31 | $1.15M 10-K · filed 2026-02-25 | ||||||
| 2022-03-31 | $11.00K 10-Q · filed 2022-05-04 | ||||||
| 2021-03-31 | $162.00K 10-Q · filed 2022-05-04 | ||||||
| 2020-12-31 | $1.43M 10-K · filed 2021-03-01 | ||||||
| 2020-03-31 | $834.00K 10-Q · filed 2021-04-28 | $1.59M derived: sum of 2 quarters · filed 2021-04-28 | $1.69M derived: sum of 3 quarters · filed 2021-04-28 | $2.00M derived: sum of 4 quarters · filed 2021-04-28 | |||
| 2019-12-31 | $756.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $860.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.16M derived: sum of 3 quarters · filed 2021-03-01 | $1.26M 10-K · filed 2021-03-01 | |||
| 2019-09-30 | $104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $405.00K derived: sum of 2 quarters · filed 2019-10-30 | $505.00K 10-Q · filed 2019-10-30 | $853.00K derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-06-30 | $301.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $401.00K 10-Q · filed 2019-07-31 | $749.00K derived: sum of 3 quarters · filed 2021-03-01 | $1.40M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-03-31 | $100.00K 10-Q · filed 2020-04-30 | $448.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.10M derived: sum of 3 quarters · filed 2021-03-01 | $14.20M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | $348.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $998.00K derived: sum of 2 quarters · filed 2021-03-01 | $14.10M derived: sum of 3 quarters · filed 2021-03-01 | $14.22M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $650.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $13.75M derived: sum of 2 quarters · filed 2019-10-30 | $13.87M 10-Q · filed 2019-10-30 | $14.46M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | $13.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $13.22M 10-Q · filed 2019-07-31 | $13.81M derived: sum of 3 quarters · filed 2020-03-02 | $13.99M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-03-31 | $123.00K 10-Q · filed 2019-05-01 | $712.00K derived: sum of 2 quarters · filed 2020-03-02 | $888.00K derived: sum of 3 quarters · filed 2020-03-02 | $6.06M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2017-12-31 | $589.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $765.00K derived: sum of 2 quarters · filed 2020-03-02 | $5.93M derived: sum of 3 quarters · filed 2020-03-02 | $5.93M 10-K · filed 2020-03-02 | |||
| 2017-09-30 | $176.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $5.35M derived: sum of 2 quarters · filed 2018-11-01 | $5.35M 10-Q · filed 2018-11-01 | $6.27M derived: sum of 4 quarters · filed 2019-03-18 | |||
| 2017-06-30 | $5.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $5.17M 10-Q · filed 2018-08-02 | $6.09M derived: sum of 3 quarters · filed 2019-03-18 | $6.32M derived: sum of 4 quarters · filed 2019-03-18 | |||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-03 | $923.00K derived: sum of 2 quarters · filed 2019-03-18 | $1.15M derived: sum of 3 quarters · filed 2019-03-18 | ||||
| 2016-12-31 | $923.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $1.15M derived: sum of 2 quarters · filed 2019-03-18 | $1.15M 10-K · filed 2019-03-18 | ||||
| 2016-09-30 | $222.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $222.00K 10-Q · filed 2017-11-02 | |||||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-09 | $609.00K 10-Q · filed 2016-08-05 | |||||
| 2015-12-31 | $948.00K 10-K · filed 2017-03-01 | $948.00K 10-K · filed 2018-02-28 | |||||
| 2015-07-24 | $0.00 10-Q · filed 2016-08-05 | ||||||
| 2015-04-24 | $0.00 10-K · filed 2018-02-28 | ||||||
| 2014-04-25 | $0.00 10-K · filed 2017-03-01 | ||||||
| 2013-04-26 | $0.00 10-KT · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |